ANTICANCER COMBINATION THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20200101079A1
SERIAL NO

16500572

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention describes anti-cancer therapies comprising using an MDM2 inhibitor in combination with a PD-1 antagonist and a LAG-3 antagonist, each as described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOEHRINGER INGELHEIM INTERNATIONAL GMBHBINGER STR 173 55216 INGELHEIM AM RHEIN GERMANY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
RESCHKE, Markus Birsfelden, CH 7 28
RUDOLPH, Dorothea Vienna, AT 22 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation